HDAC9 and Huntington disease: In 2003, a research article elucidated the effects of HDAC on HD phenotype, reporting a positive impact in an R6/2 HD murine model treated with suberoylanilide hydroxamic acid (SAHA), a well-known HDAC inhibitor.